Genome Web Breaking News
- NIH Awards Two SBIR Grants Totaling $3.9M to Phase Genomics
- Applied DNA Sciences to Provide Coronavirus Test to Stony Brook University Hospital
- Genosity, Olink Proteomics Ink Strategic Collaboration
- FDA Grants Emergency Use Authorization for Genetrack Biolabs SARS-CoV-2 Molecular Assay
- Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test
Stat
- Congressional investigation reveals Celegene, Teva plotted to keep drug prices high
- STAT Plus: Pharmalittle: Trump still insists a Covid-19 vaccine is ‘weeks away’; Regeneron antibody treatment shows promise
- STAT Plus: Telehealth startup Ro expands partnership with Pfizer to provide generic drugs
- Opinion: Online privacy loss: another Covid-19 aftershock
- STAT Plus: The health tech tracker for the fourth quarter: 14 pivotal industry events to watch
NYT science news
Xconomy news
- With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
- Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins
- Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
- Ex-Radius Health Exec Carmona Joins Rubius as Chief Financial Officer
- Freeline Therapeutics Promotes Corbau to Chief Scientific Officer
Fierce Biotech
- Medtronic to pick up Avenu Medical and its outpatient procedure for creating dialysis fistulas
- Myovant's relugolix falls short in metastatic prostate cancer with FDA verdict looming
- How the brain's immune cells could guide treatment of neurodegenerative diseases
- Moderna's COVID-19 vaccine spurs immune response in older adults
- Alnylam phase 3 links lumasiran to 'clinically significant' improvement in infants
Fierce Medical Devices
- Medtronic to pick up Avenu Medical and its outpatient procedure for creating dialysis fistulas
- FDA authorizes Hologic's high-throughput COVID-19 test for wider screening of people showing no symptoms
- Smith & Nephew to pick up Integra's orthopedics business for $240M
- Abbott nets European approval for new FreeStyle Libre glucose sensor
- AI drug designer XtalPi raises $318M from SoftBank, Tencent & others for ‘digital twin’ simulation efforts